Tag: regulatory

How Salt Selection Affects Bioavailability, Stability, and Formulation Performance The Impact of Salt, Polymorph, and Solid Form Selection on Drug Performance In the realm of pharmaceutical development, the selection of the appropriate salt, polymorph, and solid form of an Active…

Polymorphism in Pharma: Risks in API Manufacturing, Storage, and Filing Understanding Polymorphism in Pharmaceuticals: Implications for API Manufacturing and Storage Polymorphism is a significant phenomenon in the pharmaceutical industry, especially in the context of active pharmaceutical ingredient (API) development and…

Salt Screening and Polymorph Screening in Pharma: What Is the Difference? Understanding the Differences Between Salt Selection and Polymorph Screening in Pharma In the highly regulated and complex world of pharmaceuticals, the selection of the appropriate solid form of an…

Interview Questions on Salt Form and Polymorph Selection in Pharma Key Considerations for Salt, Polymorph, and Solid Form Selection in Pharmaceutical Development The selection of salts, polymorphs, and solid forms is a critical aspect of drug development that significantly influences…

Salt Form vs Free Form in Pharma: Which One Is Better and Why? Understanding Salt Forms and Free Forms in Pharmaceutical Development The choice between salt forms and free forms of active pharmaceutical ingredients (APIs) is a pivotal consideration in…

Polymorph Selection in API Development: Impact on Solubility, Stability, and Manufacturability Understanding Polymorph Selection in API Development: Effects on Solubility, Stability, and Manufacturability In the pharmaceutical industry, the development of Active Pharmaceutical Ingredients (APIs) hinges significantly on the selection of…